ADMA Biologics Inc.
ADMA | NASDAQ
$9.51
+$0.40 (+4.39%)
At close: Sep 21, 2026, 4:00 PM ET
$9.29
-$0.22 (-2.36%)
Pre-market:
Sep 22, 2026, 5:30 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 124.4M | 114.49M | 139.16M | 134.22M | 121.98M | 114.8M | 117.55M | 119.84M | 107.19M | 81.88M | 73.9M | 67.28M | 60.12M | 56.91M | 49.98M | 41.09M | 33.91M | 29.1M | 26.38M | 20.68M | 17.83M | 16.05M |
Cost of Revenue | 38.12M | 33.74M | 50.35M | 58.6M | 54.76M | 53.71M | 54.22M | 60.18M | 49.74M | 42.77M | 42.82M | 42.62M | 43.43M | 40.4M | 35.8M | 31.43M | 26.14M | 25.44M | 22.87M | 20.3M | 18.83M | 17.77M |
Gross Profit | 86.28M | 80.75M | 88.82M | 75.63M | 67.23M | 61.1M | 63.33M | 59.66M | 57.45M | 39.11M | 31.09M | 24.65M | 16.69M | 16.51M | 14.18M | 9.66M | 7.77M | 3.66M | 3.51M | 385.34K | -1M | -1.72M |
Operating Income | 52.45M | 50.29M | 62.75M | 51.01M | 42.8M | 34.88M | 38.32M | 39.64M | 39.2M | 21.82M | 14.23M | 8.69M | -473K | -813K | -6.06M | -9.32M | -9.17M | -14.82M | -13.19M | -14.44M | -15.58M | -15.16M |
Interest Income | 1.24M | 1.09M | 487K | 376K | 400K | 608K | 598K | 666K | 449K | 384K | 612.45K | 423.28K | 414.3K | 166.97K | 2.26K | 7.24K | 2.27K | 33.07K | 2.29K | 4.26K | 5.93K | 22.06K |
Pretax Income | 50.24M | 57.13M | 61.6M | 47.52M | 40.1M | 33.45M | 34.71M | 36.75M | 35.85M | 18.4M | -17.64M | 2.57M | -6.37M | -6.79M | -12.23M | -14.9M | -13.76M | -25.01M | -16.65M | -17.71M | -18.91M | -18.38M |
Net Income | 37.82M | 45.33M | 49.38M | 36.43M | 34.22M | 26.9M | 111.9M | 35.91M | 32.06M | 17.81M | -17.64M | 2.57M | -6.37M | -6.79M | -12.23M | -14.9M | -13.76M | -25.01M | -16.65M | -17.71M | -18.91M | -18.38M |
Selling & General & Admin | 26.74M | 26.74M | 23.51M | 23.05M | 22.21M | 24.08M | 23.32M | 18.56M | 16.61M | 15.64M | 15.53M | 14.73M | 14.25M | 14.51M | 13.89M | 12.89M | 11.97M | 13.7M | 11.7M | 10.73M | 10.44M | 10.03M |
Research & Development | 6.01M | 2.6M | 1.38M | 1.53M | 1.03M | 826K | 391K | 412K | 560K | 450K | 445.49K | 596K | 1.4M | 855K | 1.07M | 1.04M | 873.39K | 624.11K | 728.99K | 770.56K | 1.16M | 987.65K |
Other Expenses | 1.08M | 1.06M | 1.18M | 38K | 1.18M | 1.31M | 1.3M | 1.05M | 1.08M | 1.2M | 872.7K | 646K | 1.51M | 1.96M | 5.27M | 5.04M | 4.1M | 4.15M | 4.28M | 3.33M | 2.98M | 2.42M |
Operating Expenses | 33.83M | 30.4M | 26.07M | 24.61M | 24.43M | 26.22M | 25.01M | 20.02M | 18.25M | 17.29M | 16.85M | 15.97M | 17.16M | 17.33M | 20.24M | 18.97M | 16.94M | 18.48M | 16.7M | 14.82M | 14.58M | 13.44M |
Interest Expense | 3.42M | 2.1M | 1.63M | 1.68M | 1.83M | 1.98M | 2.88M | 3.5M | 3.78M | 3.77M | 6.21M | 6.4M | 6.3M | 6.12M | 5.74M | 5.58M | 4.57M | 3.39M | 3.32M | 3.3M | 3.25M | 3.2M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 71.95M | 64.2M | 76.41M | 83.21M | 79.19M | 79.92M | 79.23M | 80.2M | 67.99M | 60.05M | 59.67M | 58.59M | 60.6M | 57.73M | 56.04M | 50.41M | 43.08M | 43.92M | 39.57M | 35.12M | 33.41M | 31.21M |
Income Tax Expense | 12.42M | 11.8M | 12.22M | 11.09M | 5.88M | 6.55M | -77.18M | 840K | 3.79M | 595K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 228.23M | 236.07M | 237.97M | 238.6M | 241.49M | 237.78M | 236.43M | 234.57M | 232.42M | 228.87M | 225.97M | 225.28M | 222.68M | 221.92M | 202.83M | 196.38M | 196.35M | 195.87M | 180.81M | 133.77M | 126.04M | 115.66M |
Shares Outstanding (Diluted) | 230.34M | 239.96M | 243.85M | 244.66M | 248.61M | 244.68M | 245.9M | 244.8M | 242.17M | 236.41M | 225.97M | 233.76M | 222.68M | 221.92M | 202.83M | 196.38M | 196.35M | 195.87M | 180.81M | 133.77M | 127.42M | 115.66M |
EPS (Basic) | 0.17 | 0.19 | 0.21 | 0.15 | 0.14 | 0.11 | 0.47 | 0.15 | 0.14 | 0.08 | -0.08 | 0.01 | -0.03 | -0.06 | -0.06 | -0.10 | -0.07 | -0.18 | -0.09 | -0.13 | -0.15 | -0.16 |
EPS (Diluted) | 0.16 | 0.19 | 0.20 | 0.15 | 0.14 | 0.11 | 0.46 | 0.15 | 0.13 | 0.08 | -0.08 | 0.01 | -0.03 | -0.06 | -0.06 | -0.10 | -0.07 | -0.18 | -0.09 | -0.13 | -0.15 | -0.16 |
EBITDA | 57.28M | 61.07M | 65.27M | 51.21M | 43.99M | 37.39M | 39.54M | 42.19M | 41.68M | 24.28M | -9.32M | 11.06M | 2.03M | 1.36M | -4.56M | -7.46M | -7.47M | -20.03M | -11.82M | -12.99M | -14.33M | -13.95M |
EBIT | 53.66M | 59.23M | 63.22M | 49.19M | 41.93M | 35.43M | 37.59M | 40.25M | 39.63M | 22.17M | -11.43M | 8.96M | -72K | -674K | -6.49M | -9.32M | -9.19M | -21.62M | -13.33M | -14.41M | -15.66M | -15.18M |
Depreciation & Amortization | 3.62M | 1.84M | 2.05M | 2.02M | 2.06M | 1.97M | 1.94M | 1.94M | 2.05M | 2.11M | 2.11M | 2.09M | 2.1M | 2.03M | 1.94M | 1.86M | 1.72M | 1.59M | 1.52M | 1.42M | 1.33M | 1.23M |
Add to Watchlist
Select watchlists to add or remove ADMA